These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 22119637)
1. Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein. Mintzer S; Skidmore CT; Rankin SJ; Chervoneva I; Pequinot E; Capuzzi DM; Sperling MR Epilepsy Res; 2012 Jan; 98(1):88-93. PubMed ID: 22119637 [TBL] [Abstract][Full Text] [Related]
2. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin]. Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151 [TBL] [Abstract][Full Text] [Related]
3. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Mintzer S; Skidmore CT; Abidin CJ; Morales MC; Chervoneva I; Capuzzi DM; Sperling MR Ann Neurol; 2009 Apr; 65(4):448-56. PubMed ID: 19296463 [TBL] [Abstract][Full Text] [Related]
4. Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly. Mintzer S; Trinka E; Kraemer G; Chervoneva I; Werhahn KJ Epilepsia; 2018 Oct; 59(10):1899-1907. PubMed ID: 30178473 [TBL] [Abstract][Full Text] [Related]
5. Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein. Mintzer S; Miller R; Shah K; Chervoneva I; Nei M; Skidmore C; Sperling MR Epilepsy Behav; 2016 May; 58():127-32. PubMed ID: 27074299 [TBL] [Abstract][Full Text] [Related]
7. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Kim DW; Lee SY; Shon YM; Kim JH Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720 [TBL] [Abstract][Full Text] [Related]
8. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy. Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B; Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062 [TBL] [Abstract][Full Text] [Related]
9. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653 [TBL] [Abstract][Full Text] [Related]
10. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy. Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556 [TBL] [Abstract][Full Text] [Related]
13. Effects of switching pravastatin to cerivastatin on C-reactive protein, butyrylcholinesterase, and lipids. Shinn AH; Carr-Lopez SM; Smith JW; Elledge EA; Smith TJ Curr Med Res Opin; 2005 Feb; 21(2):207-14. PubMed ID: 15801991 [TBL] [Abstract][Full Text] [Related]
14. Topiramate: effects on serum lipids and lipoproteins levels in children. Franzoni E; Verrotti A; Sarajlija J; Garone C; Matricardi S; Salerno GG; Monti M; Chiarelli F Eur J Neurol; 2007 Dec; 14(12):1334-7. PubMed ID: 17916078 [TBL] [Abstract][Full Text] [Related]
15. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366 [TBL] [Abstract][Full Text] [Related]
17. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance. Varoglu AO; Yildirim A; Aygul R; Gundogdu OL; Sahin YN Clin Neuropharmacol; 2010 May; 33(3):155-7. PubMed ID: 20502135 [TBL] [Abstract][Full Text] [Related]
18. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial. Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J; Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037 [TBL] [Abstract][Full Text] [Related]
19. Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial. Elger CE; Rademacher M; Brandt C; Elmoufti S; Dedeken P; Eckhardt K; Tennigkeit F; De Backer M Epilepsy Behav; 2016 Sep; 62():1-5. PubMed ID: 27423106 [TBL] [Abstract][Full Text] [Related]
20. Malnutrition, inflammation, and lipids in a cohort of dialysis patients. Bowden RG; Wilson RL Postgrad Med; 2010 May; 122(3):196-202. PubMed ID: 20463430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]